
This case study demonstrates how system-based tobacco cessation was enhanced in a community clinic.
This case study demonstrates how system-based tobacco cessation was enhanced in a community clinic.
Despite universal access to HER2 testing in Ontario, variability in reporting by region and disease severity presents challenges for program evaluation and quality improvement initiatives.
Published: March 11th 2025 | Updated:
Published: January 21st 2013 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.